DFFN - 1.70 Pre-market now at 1.60/1.86 First Patient Enrolled in Diffusion Pharmaceuticals’ Phase 2 On-Ambulance Clinical Trial with TSC for the Treatment of Stroke https://www.tradescores.com/StockReport/dffn